ABCD Nationwide Exenatide QW Audit Publications

Papers, abstracts, presentations, posters and webcasts emanating from the audit

Webcast

 

Published papers

 

Slides from presentations

 

Abstracts
ADA New Orleans, 2016 – Robert M. Gifford, Jalini Joharatnam, Ken Darzy, Ahmed Helmy, Edward McKeever, Ursula Brennon, Roy Harper, Keith Sands, Dennis Barnes, Robert E. Ryder, Karen A. Adamson. Change in HbA1c, Weight, and Blood Pressure in the Association of British Clinical Diabetologists (ABCD) Nationwide Exenatide Once Weekly (QW) Audit. Diabetes 2016 Jul; 65 (Supplement 1): 1036-P

Posters 
ADA June 2016, Exenatide QW

The ABCD nationwide exanatide QW audit is an independent audit supported by an unrestricted grant from Astra Zeneca

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Advanced Therapeutics (UK) Ltd
  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Bronze

  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd